Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

GSK plc American Depositary Shares (Each representing two Ordinary Shares) (NY:GSK)

53.66 +2.36 (+4.60%)

Official Closing Price Updated: 4:10 PM EDT, Jul 2, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	3,802,176
Open	52.42
Bid (Size)	53.46 (100)
Ask (Size)	53.75 (300)
Prev. Close	51.30
Today's Range	52.25 - 53.84
52wk Range	35.45 - 61.70
Shares Outstanding	5,385,189,617
Dividend Yield	3.44%

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Core Restore Founder Ann Peets Announces Bladder Leak Treatments In Charleston

June 29, 2026

Via Press Release Distribution Service

Next-Generation DNA Repair Inhibitors Could Capture Billions in Emerging Market

June 24, 2026

Via Investor Brand Network

Performance

YTD	+8.1%	+8.1%
1 Month	+8.8%	+8.8%
3 Month	-4.2%	-4.2%
6 Month	+9.4%	+9.4%
1 Year	+37.8%	+37.8%

More News

BioMedNewsBreaks — Onco-Innovations Limited (CBOE CA: ONCO) (OTCQB: ONNVF) Targets Next Generation of DNA Damage Response Cancer Therapies

June 24, 2026

Via Investor Brand Network

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Arcosa, Inc. (NYSE – ACA), Fathom Holdings Inc. (Nasdaq – FTHM), Nuvalent, Inc. (Nasdaq – NUVL), Dana Incorporated (NYSE – DAN)

June 22, 2026

From Brodsky & Smith LLC

Via GlobeNewswire

GSK PLC-SPON ADR (NYSE:GSK) Passes Quality-Focused Caviar Cruise Stock Screener with Strong Profitability and Cash Flow ↗

May 19, 2026

Via Chartmill

Next-Generation DNA Repair Inhibitors Could Capture Billions in Emerging Market

June 24, 2026

From BioMedWire

Via GlobeNewswire

Utebzi (tebipenem pivoxil) approved in the US for adults with complicated urinary tract infections (cUTIs)

June 17, 2026

From GSK plc

Via Business Wire

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Nuvalent, Inc. (Nasdaq – NUVL), Dana Incorporated (NYSE – DAN), SUNation Energy, Inc. (Nasdaq – SUNE), Taylor Morrison Home Corporation (NYSE - TMHC)

June 15, 2026

From Brodsky & Smith LLC

Via GlobeNewswire

MarketBeat Week in Review – 06/08 - 06/12 ↗

June 13, 2026

Via MarketBeat

Patent Cliff Predators: GSK Acquires Nuvalent For $10.6 Billion ↗

June 11, 2026

Via MarketBeat

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Nuvalent, Inc. (Nasdaq – NUVL), SUNation Energy, Inc. (Nasdaq – SUNE), Organon & Co. (NYSE – OGN), Taylor Morrison Home Corporation (NYSE – TMHC)

June 09, 2026

From Brodsky & Smith LLC

Via GlobeNewswire

Innoviva Stock Is Up Just 10% This Past Year. Here's Why a Fund Bought $2.5 Million More ↗

May 29, 2026

Via The Motley Fool

This Income Fund Just Completely Exited Its $37 Million Stake in Algonquin Power. Why? ↗

May 18, 2026

Via The Motley Fool

Julie Bowen and Ty Burrell team up with GSK to raise awareness about meningitis risks for teens and young adults

May 07, 2026

From GSK plc

Via Business Wire

The Most Important Part of These 3 Big Pharma Earnings Reports Wasn’t the Beat ↗

May 02, 2026

Via MarketBeat

Mondrian Dumps 5.5 Million Yum China Shares Worth $284.6 Million ↗

April 29, 2026

Via The Motley Fool

Nvidia Rival Cerebras Files for an IPO: What Investors Should Know ↗

April 20, 2026

Via The Motley Fool

3 Bargain-Cheap Small Caps Worth a Second Look ↗

April 09, 2026

Via MarketBeat

The "Liberation Day" Shockwave: US Finalizes 100% Tariffs on Branded Pharmaceutical Imports

April 06, 2026

Via MarketMinute

Merck’s Oncology Empire Expands: Keytruda Secures Pivotal European Commission Approval for Recurrent Ovarian Cancer

April 02, 2026

Via MarketMinute

Moderna 2.0: The mRNA Pioneer’s Pivot to Oncology and the Path to 2028 Profitability

March 31, 2026

Via Finterra

AstraZeneca (AZN) Shares Rally After Breakthrough Chronic Lung Disease Trial Results

March 27, 2026

Via MarketMinute

The mRNA Renaissance: Moderna’s 83% Surge Leads the 2026 Healthcare Recovery

March 16, 2026

Via MarketMinute

This Biotech Stock Surged 75% Last Quarter and Pulled a New $9 Million Investment ↗

March 16, 2026

Via The Motley Fool

The $40 Billion Pivot: Kimberly-Clark and Kenvue Merger Redefines the Consumer Staples Landscape

March 16, 2026

Via MarketMinute

Frequently Asked Questions

Is GSK plc American Depositary Shares (Each representing two Ordinary Shares) publicly traded?

Yes, GSK plc American Depositary Shares (Each representing two Ordinary Shares) is publicly traded.

What exchange does GSK plc American Depositary Shares (Each representing two Ordinary Shares) trade on?

GSK plc American Depositary Shares (Each representing two Ordinary Shares) trades on the New York Stock Exchange

What is the ticker symbol for GSK plc American Depositary Shares (Each representing two Ordinary Shares)?

The ticker symbol for GSK plc American Depositary Shares (Each representing two Ordinary Shares) is GSK on the New York Stock Exchange

What is the current price of GSK plc American Depositary Shares (Each representing two Ordinary Shares)?

The current price of GSK plc American Depositary Shares (Each representing two Ordinary Shares) is 53.66

When was GSK plc American Depositary Shares (Each representing two Ordinary Shares) last traded?

The last trade of GSK plc American Depositary Shares (Each representing two Ordinary Shares) was at 07/02/26 04:10 PM ET

What is the market capitalization of GSK plc American Depositary Shares (Each representing two Ordinary Shares)?

The market capitalization of GSK plc American Depositary Shares (Each representing two Ordinary Shares) is 288.97B

How many shares of GSK plc American Depositary Shares (Each representing two Ordinary Shares) are outstanding?

GSK plc American Depositary Shares (Each representing two Ordinary Shares) has 289B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.